Technicals for Alembic Pharmaceuticals Limited
The PSAR remains in a bearish mode, setting a strong resistance level...
The PSAR remains in a bearish mode, setting a strong resistance level...
APLLTD's low Debt-to-Equity ratio demonstrates that the company is not over-leveraged. This...
The list of all important regulatory filings for Alembic Pharmaceuticals Limited which...
An analysis of the potential for a Federal Reserve rate cut in...
An analytical overview of the factors influencing gold prices in 2025, examining...
An in-depth analysis of the current exchange rate dynamics of the Indian...
Published | Title | Summary |
---|---|---|
2025-07-03 17:21:18 | Acquisition-XBRL | Alembic Pharmaceuticals Limited has informed the Exchange regarding Acquisition... |
2025-01-22 16:54:37 | Board Meeting Intimation | Alembic Pharmaceuticals Limited has informed the Exchange about Board Meeting... |
2024-10-18 12:04:54 | Board Meeting Intimation | ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2024-07-25 16:51:48 | Board Meeting Intimation | ALEMBIC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2024-05-09 14:06:37 | Dividend | Alembic Pharmaceuticals Limited has informed the Exchange that Board of... |
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Lists of companies in NSE500 with the best and the worst technicals...
The article examines the current dynamics of the U.S. dollar's strength, focusing...
An in-depth analysis of recent earnings season reports, evaluating whether improvements are...
The article discusses the implications of the Eurozone CPI at 2.1% regarding...